Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00292253
Status:
COMPLETED
Last Update Posted:
2013-08-06
First Post:
2006-02-13
Brief Title:
Tolerability of Rebif Injection With and Without the Use of RebijectMini in Relapsing-Remitting Multiple Sclerosis Subjects
Sponsor:
EMD Serono
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
22982
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Serono International SA | INDUSTRY |